Next-Generation Fluorescence Optimization Systems

Publication ID: 24-11857643_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Fluorescence Optimization Systems,” Published Technical Disclosure No. 24-11857643_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857643_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,643.

Summary of the Inventive Concept

This inventive concept discloses novel systems, methods, and compositions that revolutionize fluorescence-based applications by providing real-time optimization, super-resolution imaging, and single-molecule detection capabilities.

Background and Problem Solved

The original patent disclosed methods for enhancing fluorescence signals and reducing quenching. However, these methods have limitations in terms of real-time optimization, spatial resolution, and single-molecule detection. The new inventive concept addresses these limitations by introducing a paradigm shift in fluorescence technology.

Detailed Description of the Inventive Concept

The inventive concept comprises four main aspects: 1) a system for real-time fluorescence optimization using microfluidic devices and machine learning algorithms; 2) a method for generating super-resolution fluorescent images using labels with distinct spectral signatures and computational deconvolution; 3) a composition for fluorescence-based single-molecule detection featuring photostable fluorescent labels with cleavable linkers; and 4) a device for multiplexed fluorescence analysis using micro-optical elements and spectral detectors.

Novelty and Inventive Step

The new inventive concept introduces a fundamental shift in fluorescence technology by integrating real-time optimization, super-resolution imaging, and single-molecule detection capabilities. The use of microfluidic devices, machine learning algorithms, and novel label compositions provides a non-obvious solution to the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of other types of microfluidic devices, different machine learning algorithms, or various label compositions. Variations of the device for multiplexed fluorescence analysis could include the use of different micro-optical elements or spectral detectors.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including biomedical research, diagnostics, and pharmaceutical development. The ability to provide real-time fluorescence optimization, super-resolution imaging, and single-molecule detection capabilities could revolutionize the field of fluorescence-based applications.

CPC Classifications

SectionClassGroup
A A61 A61K49/0015
A A61 A61K47/10
A A61 A61K47/18
A A61 A61K49/0058
G G01 G01N33/533
G G01 G01N33/582
G G01 G01N33/68

Field of Art

Fluorescence biotechnology, specifically biomolecule labeling techniques, molecular imaging, and diagnostic assay development, requiring expertise in biochemistry, optical engineering, and molecular biology

Person of Ordinary Skill (PHOSITA) Profile

A PhD or equivalent professional with advanced training in fluorescence techniques, experience with protein conjugation, microscopy, and computational image analysis, familiar with state-of-the-art labeling strategies and optical detection methods

Obviousness Rationale

A PHOSITA would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core fluorescence enhancement techniques, applying known microfluidic, computational, and labeling strategies to incrementally improve biomolecule fluorescence detection and imaging capabilities. The technical solutions proposed are logical combinations of existing methodological approaches within the fluorescence biotechnology domain.

Obvious Combinations & Variations

Source Patent Element
Conjugating spacer molecules to reduce fluorescent label quenching
PTD Variation
Using microfluidic devices to dynamically adjust dye-to-protein ratios for optimized fluorescence
Obviousness Reasoning
A PHOSITA would find it obvious to extend spacer molecule optimization techniques using real-time microfluidic platforms, as both aim to improve fluorescence signal through strategic molecular configuration
Source Patent Element
Conjugating two to ten fluorescent labels to an antibody
PTD Variation
Generating super-resolution images using labels with distinct spectral signatures
Obviousness Reasoning
Expanding label multiplexing strategies is a predictable progression in fluorescence technology, representing a known technique for enhancing molecular detection capabilities
Source Patent Element
Fluorescently labeled biomolecules for cellular imaging
PTD Variation
Single-molecule detection using photostable fluorescent labels with cleavable linkers
Obviousness Reasoning
Improving molecular detection sensitivity through advanced labeling techniques is an expected evolutionary step in fluorescence biotechnology
Source Patent Element
Reducing fluorescent quenching through strategic molecular conjugation
PTD Variation
Machine learning algorithms for predicting optimal fluorescence conditions
Obviousness Reasoning
Applying computational methods to optimize fluorescence signal is a logical extension of existing signal enhancement strategies, representing a predictable technological advancement
Source Patent Element
Fluorescent biomolecule labeling methods
PTD Variation
Multiplexed fluorescence analysis using micro-optical elements and spectral detectors
Obviousness Reasoning
Enhancing detection capabilities through advanced optical systems is a foreseeable progression in fluorescence imaging technology
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857643 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and therefore unpatentable, as the proposed methods represent predictable combinations of known fluorescence enhancement techniques utilizing standard biotechnological approaches.

Original Patent Information

Patent NumberUS 11,857,643
TitleCompositions and methods for enhanced fluorescence
Assignee(s)Life Technologies Corporation, Pierce Biotechnology, Inc.